Purchase Order HHSN276200900643P
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Miltenyi Biotec, Inc. in the amount of $24,646.00. The contract is for the delivery of Miltenyi's GentleMACS instruments and associated products, which are used for cell separation, analysis, and processing in biomedical research. Miltenyi Biotec is a global biotechnology company that provides specialized scientific equipment, reagents, and...
- This is a $17,976 firm fixed price purchase order awarded to Miltenyi Biotec, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for laboratory equipment and supplies. The contract is not set aside. Miltenyi Biotec is a global biotechnology company that specializes in cell separation, analysis, and processing technologies. Under this contract, the company will provide a variety of products and services to support biomedical...
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This is a fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $4,250 contract is for the supply of specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Miltenyi Biotec has significant experience as a prime contractor for various...
- This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
- This $4,884 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is not associated with a set-aside. Under this award, Miltenyi Biotec will supply the NIH Clinical Center with proprietary CliniMACS cell isolation reagents and consumables required for Good...
- This $6,929.75 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized instruments, reagents, and services for biomedical research and cell therapy development. The contract does not have a set-aside designation. Miltenyi Biotec is delivering a range of products and services to support NIAID's research programs, particularly in areas such as cancer,...
- This is a $312,065 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company specializing in cell therapy products and instruments. The contract provides for the delivery and installation of specialized laboratory equipment such as CliniMACS Prodigy cell processing systems, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as proprietary cell isolation reagents and...
- This is a $23,230 firm fixed-price purchase order contract awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute on Aging, a civilian federal agency. The contract delivers specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation, including flow cytometers, cell sorters, tissue dissociators, automated cell separation systems, and associated consumables. Miltenyi Biotec has an...
- This is a $4,250 firm-fixed-price purchase order contract between the National Institute of Allergy and Infectious Diseases (NIAID) and Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is not set aside and supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Miltenyi Biotec has extensive experience as a prime contractor for numerous...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The $4,250.00 contract does not have a set-aside designation. The contract provides for the delivery and installation of Miltenyi Biotec's specialized laboratory equipment, including CliniMACS Prodigy cell processing systems, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as associated proprietary reagents, microbeads, and consumables used in cell isolation and analysis. The company also provides maintenance, repair, and technical support services for these instruments at government facilities. This contract supports biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Additionally, Miltenyi Biotec holds a $2.3 million indefinite delivery contract (IDC) with the NIH Clinical Center, awarded in June 2023, to supply proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027. This sole-source contract ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation to support the agency's cell processing and manufacturing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/24/09 |